Ticker League

EBITDA Margin for Abbott Laboratories (ABT)

As of · Reported

Metric

TTM

23.9%

YoY change

+0.24pp

Trough year (2012)

8.8%

Peak year (1998)

31.3%

EBITDA Margin history chart for Abbott Laboratories (ABT) from 1985 to 2025

Latest: 26.1%

EBITDA Margin change chart for Abbott Laboratories (ABT) from 1985 to 2025

Latest: +0.24pp

EBITDA Margin history table for Abbott Laboratories (ABT) from 1985 to 2025

  • 202526.1%+0.24pp
  • 202425.8%-0.61pp
  • 202326.4%-0.79pp
  • 202227.2%-0.99pp
  • 202128.2%+2.21pp
  • 202026.0%+1.22pp
  • 201924.8%+2.29pp
  • 201822.5%+0.11pp
  • 201722.4%+7.67pp
  • 201614.7%-8.96pp
  • 201523.7%+3.16pp
  • 201420.5%+4.03pp
  • 201316.5%+7.73pp
  • 20128.8%-15.07pp
  • 201123.8%-2.15pp
  • 201026.0%-4.87pp
  • 200930.9%+3.01pp
  • 200827.9%+1.16pp
  • 200726.7%+7.78pp
  • 200618.9%-8.93pp
  • 200527.8%-0.68pp
  • 200428.5%+7.18pp
  • 200321.3%-2.98pp
  • 200224.3%-2.64pp
  • 200127.0%-3.79pp
  • 200030.8%+0.58pp
  • 199930.2%-1.10pp
  • 199831.3%+1.30pp
  • 199730.0%-0.01pp
  • 199630.0%+0.54pp
  • 199529.5%+0.46pp
  • 199429.0%+0.35pp
  • 199328.6%+3.76pp
  • 199224.9%-3.27pp
  • 199128.2%-0.46pp
  • 199028.6%+0.20pp
  • 198928.4%+0.60pp
  • 198827.8%-0.67pp
  • 198728.5%+0.16pp
  • 198628.3%+1.74pp
  • 198526.6%—

EBITDA Margin values are taken from Abbott Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Abbott Laboratories (ABT)

According to Abbott Laboratories's latest reported financial statements, the company's latest reported EBITDA margin is 23.9%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Abbott Laboratories (ABT) most recent annual EBITDA margin stands at 26.06% (2025) – expanded 0.2 percentage points year-over-year.

1998 marks the peak EBITDA margin at 31.29%, with the historical low of 8.77% recorded in 2012.

Abbott Laboratories EBITDA Margin by Year

Abbott Laboratories EBITDA Margin 2025: 26.1%

Abbott Laboratories EBITDA margin in 2025 was 26.06%, expanded 0.2 percentage points from 2024.

Abbott Laboratories EBITDA Margin 2024: 25.8%

2024's EBITDA margin for Abbott Laboratories came in at 25.83%, contracted 0.6 percentage points from 2023.

Abbott Laboratories EBITDA Margin 2023: 26.4%

Abbott Laboratories posted EBITDA margin of 26.44% in 2023, contracted 0.8 percentage points from 2022.

Abbott Laboratories EBITDA Margin 2022: 27.2%

In 2022, Abbott Laboratories reported EBITDA margin of 27.23%, contracted 1.0 percentage points from 2021.

Abbott Laboratories EBITDA Margin 2021: 28.2%

Abbott Laboratories EBITDA margin in 2021 was 28.23%.

See more financial history for Abbott Laboratories (ABT).

Sector peers by EBITDA Margin

Healthcare peers of Abbott Laboratories (ABT), ranked by their latest EBITDA margin

Frequently asked questions

Abbott Laboratories (ABT) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview